Impax Asset Management Group PLC Bio Rad Laboratories, Inc. Transaction History

Impax Asset Management Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$350.25 - $422.63 $11,908 - $14,369	-34 Reduced 1.81%	1,845 $661,000
Q2 2023 Aug 07, 2023	BUY	$359.49 - $486.4 $287,592 - $389,120	800 Added 74.14%	1,879 $712,000
Q4 2022 Feb 09, 2023	SELL	$351.71 - $456.01 $15,123 - $19,608	-43 Reduced 3.83%	1,079 $453,000
Q3 2022 Nov 08, 2022	SELL	$412.59 - $563.26 $18,979 - $25,909	-46 Reduced 3.94%	1,122 $468,000
Q1 2022 May 16, 2022	SELL	$524.57 - $735.42 $3,147 - $4,412	-6 Reduced 0.51%	1,168 $658,000
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $22,682 - $25,429	-32 Reduced 2.65%	1,174 $887,000
Q1 2021 May 14, 2021	BUY	$547.01 - $662.35 $659,694 - $798,794	1,206 New	1,206 $689,000

479

19.2M

15.7K

11.5K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.53B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

Stay updated on Impax Asset Management Group PLC with notifications on news.